- Hlavní
- Analytika
- Zprávy z trhu
- Company news: Amgen’s (AMGN) quarterly earnings beat analysts’ forecasts
Ekonomické zprávy
31.10.2024
Company news: Amgen’s (AMGN) quarterly earnings beat analysts’ forecasts
Amgen (AMGN) reported Q3 FY2024 earnings of $5.58 per share (versus $4.96 per share in Q3 FY2023), beating analysts’ consensus estimate of $5.11 per share.
The company’s quarterly revenues amounted to $8.503 bln (+23.2% y/y), matching analysts’ consensus estimate of $8.503 bln.
The company also issued in-line guidance for FY2024, seeing EPS of $19.20-$20.00 versus its prior guidance of $19.10-$20.10 and analysts’ consensus estimate of $19.52 and revenues of $33.0-$33.8 bln versus its prior guidance of $32.8-$33.8 bln and analysts’ consensus estimate of $33.21 bln.
AMGN rose to $316.01 (+0.15%) in pre-market trading.
Podívejte se také